Literature DB >> 6763056

Growth hormone secretion in empty sella syndrome.

K Brismar.   

Abstract

GH secretion was studied in 47 patients with empty sella syndrome (ESS), using the GH response to the L-dopa test and determinations of the somatomedin levels. A high frequency of low responders (56%) was found, which is in accordance with previous reports on ESS. However, a true GH deficiency as judged by low levels of somatomedin A, was suspected in only 2 out of 41 patients with otherwise normal pituitary function and in 5 out of 6 patients with other pituitary insufficiences. The impaired GH responsiveness in the remaining patients seemed to be attributed to their overweight and/or postmenopausal age (estrogen deficiency) and not to a true GH deficiency, which was excluded by normal levels of somatomedin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6763056     DOI: 10.1007/BF03350543

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  The volume of the sella turcica.

Authors:  G DI CHIRO; K B NELSON
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-06

2.  Apomorphine: effect on growth hormone.

Authors:  I Maany; A Frazer; J Mendels
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

3.  Immunoreactive somatomedin A in human serum.

Authors:  K Hall; J Brandt; G Enberg; L Fryklund
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

4.  Radioreceptor assay for somatomedin A.

Authors:  K Hall; K Takano; L Fryklund
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

5.  [Anomalies of growth hormone regulation].

Authors:  J Heim
Journal:  Lille Med       Date:  1979-02

6.  Plasma growth hormone response to L-dopa in obese subjects.

Authors:  M Fingerhut; D T Krieger
Journal:  Metabolism       Date:  1974-03       Impact factor: 8.694

7.  Studies of the sex based variation of human growth hormone secretion.

Authors:  T J Merimee; S E Fineberg
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

8.  [Headache, visual disturbance and amblyopic attack associated with sellar enlargement--primary empty sella syndrome (author's transl)].

Authors:  M Tomonaga; T Fukushima
Journal:  No Shinkei Geka       Date:  1978-12

9.  Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.

Authors:  A Galea-Debono; P Jenner; C D Marsden; J D Parkes; D Tarsy; J Walters
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

10.  Growth hormone response to propranolol and L--dopa in obese subjects.

Authors:  A Barbarine; L De Marinis; L Troncone
Journal:  Metabolism       Date:  1978-03       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.